facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2017
vol. 104
 
Share:
Share:
abstract:
Case report

Combination therapy with prednisone and cyclophosphamide in a 14-year-old boy with pemphigus foliaceus – a case report

Magdalena Salińska
,
Kamil Trambowicz
,
Joanna Narbutt
,
Anna Woźniacka
,
Aleksandra Lesiak

Dermatol Rev/Przegl Dermatol 2017, 104, 324–330
Online publish date: 2017/07/05
View full text Get citation
 
PlumX metrics:
Introduction. Pemphigus foliaceus is a dermatosis rarely occurring in the paediatric population.

Objective. To draw attention to diagnostic and therapeutic difficulties associated with pemphigus foliaceus.

Case report. A 14-year-old boy was admitted to our department with seborrhoeic crusts over the anterior and posterior surfaces of the chest and erythematous-infiltrative lesions in the axillary and popliteal fossae. Since histopathological examination revealed features of Darier’s disease, acitretin treatment was initiated. No improvement was noted after 3 months. Another skin biopsy was obtained and immunologic tests were carried out. Based on the clinical manifestations and results of additional tests, juvenile pemphigus foliaceus was diagnosed. Prednisone therapy was initiated, however it failed to produce satisfactory improvement in skin lesions. Cyclophosphamide was added to prednisone, causing remission of the disease.

Conclusions. In patients with non-characteristic lesions who fail to respond to treatment it is advisable to extend diagnostics by immunologic tests. In the reported case combination therapy with prednisone and cyclophosphamide led to long-term remission, causing no adverse effects.
keywords:

pemphigus foliaceus, immunosuppressive therapy, Darier’s disease, cyclophosphamide, paediatric patient



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.